Magnesium Sleep Onset Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Sleep Onset Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 preclinical study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• An alarming 40-70% of older adults are estimated to have chronic sleep problems, which consequently increases the risk of detrimental health outcomes, including physical ailments, mental health issues, and cognitive decline. [VanderMark Esther (2026); evidence level 2]
• Thus, there is an urgent need to identify safe, non-pharmacological strategies that optimize sleep to support healthy aging in older adults and to minimize adverse outcomes that result from poor sleep. [VanderMark Esther (2026); evidence level 2]
• Sleep is a complex biological process whose evolutionary purpose has remained equivocal for quite some time.More recently, however, compelling evidence has emerged, leading to recognition of the numerous metabolic and physiological functions sleep contributes to and actively supports. [Conti Federica (2026); evidence level 4]
• Epidemiological studies have revealed that sleep deprivation is associated with an increased risk of all-cause mortality,alongside numerous chronic conditions imposing a heavy burden on our healthcare and socioeconomic systems alike,including cardiovascular disease, stroke, obesity, type 2 diabetes, and various types of cancer and neurological disorders. [Conti Federica (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For magnesium sleep onset randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• VanderMark Esther (2026). CherryZZZ: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study Testing Tart Cherry Juice in Older Adults with Self-Reported Insomnia. DOI: 10.3390/nu18060922. PMCID: PMC13029778. PMID: 41901097. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13029778/
• Conti Federica (2026). Dietary Protocols to Promote and Improve Restful Sleep: A Narrative Review. DOI: 10.1093/nutrit/nuaf062. PMCID: PMC13075487. PMID: 40418260. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13075487/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.